EGFR and lung adenocarcinoma: Several oncogenic drivers have been identified in lung adenocarcinoma, including mutations in the epidermal growth factor receptor (EGFR) [8], fusions of anaplastic lymphoma kinase (ALK) [9], and rearrangements of ROS proto-oncogene 1 receptor tyrosine kinase (ROS1) [10].